540 related articles for article (PubMed ID: 30179746)
1. Quinolone derivatives and their activities against methicillin-resistant Staphylococcus aureus (MRSA).
Gao C; Fan YL; Zhao F; Ren QC; Wu X; Chang L; Gao F
Eur J Med Chem; 2018 Sep; 157():1081-1095. PubMed ID: 30179746
[TBL] [Abstract][Full Text] [Related]
2. Recent developments of quinolone-based derivatives and their activities against Escherichia coli.
Gao F; Wang P; Yang H; Miao Q; Ma L; Lu G
Eur J Med Chem; 2018 Sep; 157():1223-1248. PubMed ID: 30193220
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibitory activity of N-acetylcysteine on tympanostomy tube biofilms from methicillin-resistant Staphylococcus aureus and quinolone-resistant Pseudomonas aeruginosa.
Jun Y; Youn CK; Jo ER; Cho SI
Int J Pediatr Otorhinolaryngol; 2019 Nov; 126():109622. PubMed ID: 31404783
[TBL] [Abstract][Full Text] [Related]
4. In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
Kanayama S; Ikeda F; Okamoto K; Nakajima A; Matsumoto T; Ishii R; Amano A; Matsuzaki K; Matsumoto S
J Infect Chemother; 2016 Oct; 22(10):720-3. PubMed ID: 27091753
[TBL] [Abstract][Full Text] [Related]
5. Anti-methicillin-resistant Staphylococcus aureus assay of azalomycin F5a and its derivatives.
Yuan GJ; Li PB; Yang J; Pang HZ; Pei Y
Chin J Nat Med; 2014 Apr; 12(4):309-13. PubMed ID: 24863359
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA).
Song MX; Zheng CJ; Deng XQ; Sun LP; Wu Y; Hong L; Li YJ; Liu Y; Wei ZY; Jin MJ; Piao HR
Eur J Med Chem; 2013 Feb; 60():376-85. PubMed ID: 23314051
[TBL] [Abstract][Full Text] [Related]
7. Anti-infective drug development for MRSA.
Daniel A
Methods Mol Biol; 2014; 1085():311-31. PubMed ID: 24085703
[TBL] [Abstract][Full Text] [Related]
8. Identification of CH
Dai H; Hu Y; Zhang Y; Zhu Q; Xu T; Cui P; Fan R; He Q
Eur J Med Chem; 2024 May; 271():116399. PubMed ID: 38640868
[TBL] [Abstract][Full Text] [Related]
9. Membrane active 7-thiazoxime quinolones as novel DNA binding agents to decrease the genes expression and exert potent anti-methicillin-resistant Staphylococcus aureus activity.
Chen JP; Battini N; Ansari MF; Zhou CH
Eur J Med Chem; 2021 May; 217():113340. PubMed ID: 33725630
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus.
Gatadi S; Gour J; Shukla M; Kaul G; Das S; Dasgupta A; Malasala S; Borra RS; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2018 Sep; 157():1056-1067. PubMed ID: 30176536
[TBL] [Abstract][Full Text] [Related]
11. Exploration of the activity of 7-pyrrolidino-8-methoxyisothiazoloquinolones against methicillin-resistant Staphylococcus aureus (MRSA).
Kim HY; Wiles JA; Wang Q; Pais GC; Lucien E; Hashimoto A; Nelson DM; Thanassi JA; Podos SD; Deshpande M; Pucci MJ; Bradbury BJ
J Med Chem; 2011 May; 54(9):3268-82. PubMed ID: 21425851
[TBL] [Abstract][Full Text] [Related]
12. Quinolone alkaloids from Fructus Euodiae show activity against methicillin-resistant Staphylococcus aureus.
Pan X; Bligh SW; Smith E
Phytother Res; 2014 Feb; 28(2):305-7. PubMed ID: 24497124
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
Emami S; Foroumadi A; Faramarzi MA; Samadi N
Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial use and methicillin-resistant Staphylococcus aureus in a large nursing home.
Drinka PJ; Gauerke C; Le D
J Am Med Dir Assoc; 2004; 5(4):256-8. PubMed ID: 15228636
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and antibacterial evaluation of novel derivatives of NPS-2143 for the treatment of methicillin-resistant S. aureus (MRSA) infection.
Chen Y; Ju Y; Li C; Yang T; Deng Y; Luo Y
J Antibiot (Tokyo); 2019 Jul; 72(7):545-554. PubMed ID: 30940910
[TBL] [Abstract][Full Text] [Related]
16. Topological pattern for the search of new active drugs against methicillin resistant Staphylococcus aureus.
Bueso-Bordils JI; Perez-Gracia MT; Suay-Garcia B; Duart MJ; Martin Algarra RV; Lahuerta Zamora L; Anton-Fos GM; Aleman Lopez PA
Eur J Med Chem; 2017 Sep; 138():807-815. PubMed ID: 28734246
[TBL] [Abstract][Full Text] [Related]
17. Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization.
Remy JM; Tow-Keogh CA; McConnell TS; Dalton JM; Devito JA
J Antimicrob Chemother; 2012 Dec; 67(12):2814-20. PubMed ID: 22875850
[TBL] [Abstract][Full Text] [Related]
18. Molecular characteristics of community-acquired methicillin-resistant Staphylococcus aureus in Hokkaido, northern main island of Japan: identification of sequence types 6 and 59 Panton-Valentine leucocidin-positive community-acquired methicillin-resistant Staphylococcus aureus.
Kawaguchiya M; Urushibara N; Kuwahara O; Ito M; Mise K; Kobayashi N
Microb Drug Resist; 2011 Jun; 17(2):241-50. PubMed ID: 21395449
[TBL] [Abstract][Full Text] [Related]
19. Pyrazole-based analogs as potential antibacterial agents against methicillin-resistance staphylococcus aureus (MRSA) and its SAR elucidation.
Verma R; Verma SK; Rakesh KP; Girish YR; Ashrafizadeh M; Sharath Kumar KS; Rangappa KS
Eur J Med Chem; 2021 Feb; 212():113134. PubMed ID: 33395624
[TBL] [Abstract][Full Text] [Related]
20. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
